Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection [Phase 1, Phase 2]
Clinical trial update for a recombinant anti-HER2 monoclonal antibody in early phases for HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer [Phase 2]
Phase 2 trial update of Abraxane in patients with visceral metastases-dominant metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. [Phase 2]
Phase II trial comparing everolimus with exemestane, everolimus alone, and capecitabine in advanced breast cancer has completed with posted …
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy [Phase 3]
Phase 3 trial comparing wide margin versus narrow margin in postneoadjuvant lumpectomy for breast cancer is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2021-02-25Clinical Trial Update: Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy [Phase 3]
A Phase 3 trial evaluating individualized locoregional treatment after primary systemic therapy for node-positive breast cancer has been wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer [Phase 3]
Phase 3 trial comparing liposomal doxorubicin versus observation or cyclophosphamide and methotrexate in older women after breast cancer sur…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Abiraterone Acetate in Molecular Apocrine Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating abiraterone acetate in molecular apocrine breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery [Phase 4]
Phase 4 trial investigating the effect of dexmedetomidine on the duration of analgesia from an erector spinae plane block in breast cancer p…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer [Phase 4]
A single-arm Phase 4 clinical trial assessing brain metastasis in patients with HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: SEroma Reduction pOst MAstectomy "SEROMA Study" [Phase 4]
Phase 4 clinical trial update investigating seroma reduction after mastectomy (SEROMA Study) with unclear current status.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer [Phase 2]
Phase II study update of Herzuma plus gedatolisib in HER2-positive metastatic breast cancer is being conducted; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer [Phase 2, Phase 3]
A clinical trial investigating capecitabine and albumin-stabilized nanoparticle formulation with paclitaxel in women undergoing surgery for …
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment [NA]
A completed clinical trial evaluating ultrasound and near-infrared imaging to predict and monitor neoadjuvant treatment in breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating MEDI4736 (durvalumab) added to taxane-anthracycline chemotherapy for triple-negative breast cancer has compl…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer [Phase 2, Phase 3]
A neoadjuvant combined hormone therapy trial is being conducted in premenopausal women with locally advanced ER+/HER2- breast cancer in Phas…
-
FDA approval · 2021-02-11FDA Approved: EVEROLIMUS — Original Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's original application (ANDA) for Everolimus, a generic version of the mTOR inhibitor. The approval enables a g…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer [Phase 2, Phase 3]
A comparative phase 2/3 trial evaluating docetaxel plus carboplatin versus epirubicin plus cyclophosphamide followed by docetaxel as adjuvan…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane [Phase 4]
Phase 4 trial of trastuzumab emtansine in Indian patients with HER2-positive unresectable locally advanced or metastatic breast cancer who p…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer. [Phase 2]
Phase II study of alternating eribulin and hormonal therapy in pre-treated ER-positive breast cancer has been terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts [NA]
This clinical trial update reports results from a study evaluating abbreviated breast MRI and digital tomosynthesis mammography for breast c…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients [Phase 3]
Phase 3 trial investigating Cicaderma versus standard care to prevent radiodermatitis in non-metastatic breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer [Phase 3]
A Phase 3 trial comparing docetaxel, doxorubicin, and cyclophosphamide versus vinorelbine and capecitabine as preoperative treatment for loc…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway [Phase 3]
Phase 3 clinical trial evaluating inetetamab with rapamycin and chemotherapy for HER2-positive metastatic breast cancer with abnormal PAM pa…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Prevention and Treatment of Pyrrolitinib-associated Diarrhea [Phase 2, Phase 3]
Phase 2/3 trial update evaluating prevention and treatment of diarrhea associated with pyrrolitinib in breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial of eribulin with cyclophosphamide in malignant solid tumors and metastatic/recurrent breast cancer; study completed with res…